# US 2013/0231391 A1 · Adamantane derivatives possessing anti-viral and anti-microbial activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0231391 A1
- Document ID: US20130231391A1
- Status: Published application
- Kind: A1
- Application number: 13/768,316
- Filed: 2013-02-15
- Published: 2013-09-05
- Earliest claimed: 2012-02-21
- Assignees: Vymed Corporation
- Inventors: B. Vithal SHETTY
- Web page: https://patentgrep.com/patent/US20130231391A1

## CPC

- C07C 239/04: N-halogenated amines
- C07C 211/38: containing condensed ring systems
- C07C 2603/74: Adamantanes
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present invention relates to adamantane derivatives that are active as antiviral and anti-microbial agents; antiviral or antibacterial compositions comprising adamantane derivatives or pharmaceutically acceptable salts thereof; and methods of preventing or treating viral or bacterial infections in mammalian hosts through the administration of adamantine derivatives or their salts or pharmaceutical compositions comprising the same. In particular, viral infections prevented or treated by the methods of the present invention may include, but are not limited to, those caused by arenavirus or one or more pox viruses, such as vaccinia and/or variola.

## Claims

### Claim 1

An adamantane derivative, or pharmaceutically acceptable salt thereof, represented by the following general formula:
wherein R1 and R2 independently comprise 1-adamantane, 2-adamantane and noradamantane;
wherein R3 and R4 independently comprise hydrogen, halogen or a low MW alkyl;
and wherein n represents a number from 1 to 6.

### Claim 2 (depends on 1)

An antiviral composition which comprises:
(a) an effective amount of a compound of claim 1; and
(b) a pharmaceutically acceptable carrier.

### Claim 3 (depends on 1)

An antibacterial composition which comprises:
(a) an effective amount of a compound of claim 1; and
(b) a pharmaceutically acceptable carrier.

### Claim 4 (depends on 1)

An antiviral and antibacterial composition which comprises:
(a) an effective amount of a compound of claim 1; and
(b) a pharmaceutically acceptable carrier.

### Claim 5 (depends on 1)

A method for preventing or treating a bacterial infection in a mammalian host, said method comprising administering to a mammal in need thereof an effective amount of a compound of claim 1.

### Claim 6 (depends on 1)

A method for preventing or treating a viral infection in a mammalian host, said method comprising administering to mammal in need thereof an effective amount of a compound of claim 1.

### Claim 7 (depends on 1)

A method for preventing or treating a viral infection in a mammalian host, wherein said viral infection is caused by vaccinia virus, said method comprising administering to a mammal in need thereof an effective amount of a compound of claim 1.

### Claim 8 (depends on 1)

A method for preventing or treating a viral infection in a mammalian host, wherein said viral infection is caused by variola virus, and wherein said method comprising administering to a mammal in need thereof an effective amount of a compound of claim 1.

### Claim 9 (depends on 1)

A method for preventing or treating a viral infection in a mammalian host, wherein said viral infection is caused by an arenavirus, and wherein said method comprising administering to a mammal in need thereof an effective amount of a compound of claim 1.
